Malkin Alexis G, Goldstein Judith E, Massof Robert W
a New England College of Optometry , Boston , MA , USA.
b Johns Hopkins University School of Medicine , Baltimore , MD , USA.
Ophthalmic Epidemiol. 2017 Jun;24(3):174-180. doi: 10.1080/09286586.2016.1257027. Epub 2017 Jan 3.
To understand the source of between-person variance in baseline health utilities estimated from EuroQol 5-dimension questionnaire (EQ-5D) responses of a representative sample of the US low vision outpatient population prior to rehabilitation.
A prospective, observational study of 779 new low vision patients at 28 clinic centers in the US. The EQ-5D, Activity Inventory (AI), Telephone Interview for Cognitive Status (TICS), Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) physical functioning component, and Geriatric Depression Scale (GDS) were administered by telephone interview prior to rehabilitation. EQ-5D responses were transformed into health utilities, which served as the dependent variable in all analyses. Data were then analyzed to determine how much overall visual ability, functional domains of visual ability, and comorbidities (e.g. physical functioning, depression, cognition) independently contribute to the EQ-5D-based health utility index.
Multivariable regression analyses showed that the GDS and SF-36 physical account for nearly 40% of the variance observed in health utilities estimated from EQ-5D responses of low vision patients. Age was also a significant predictor of health utilities, but accounted for very little variance. None of the other variables were significant predictors.
Health utilities of low vision patients estimated from the EQ-5D primarily are associated with comorbid factors that are not likely to be responsive to low vision rehabilitation, thereby rendering the EQ-5D an unsuitable outcome measure for this population. However, because the EQ-5D is responsive to comorbid states, it could be a useful tool for evaluating the impact of comorbidities on low vision patient quality of life.
了解在美国低视力门诊康复前代表性样本中,根据欧洲五维健康量表(EQ - 5D)反应估计的个体间基线健康效用差异的来源。
对美国28个诊所中心的779名新的低视力患者进行前瞻性观察研究。在康复前通过电话访谈进行欧洲五维健康量表(EQ - 5D)、活动量表(AI)、认知状态电话访谈(TICS)、医学结局研究36项简短健康调查(SF - 36)身体功能部分以及老年抑郁量表(GDS)的评估。EQ - 5D反应被转换为健康效用,其作为所有分析中的因变量。然后对数据进行分析,以确定整体视觉能力、视觉能力功能域以及合并症(如身体功能、抑郁、认知)如何独立地对基于EQ - 5D的健康效用指数产生影响。
多变量回归分析表明,老年抑郁量表(GDS)和SF - 36身体功能部分占低视力患者EQ - 5D反应估计的健康效用中观察到的近40%的差异。年龄也是健康效用的一个显著预测因素,但占差异的比例非常小。其他变量均不是显著的预测因素。
根据EQ - 5D估计的低视力患者的健康效用主要与不太可能对低视力康复有反应的合并症因素相关,从而使得EQ - 5D不适用于该人群的结局测量。然而,由于EQ - 5D对合并症状态有反应,它可能是评估合并症对低视力患者生活质量影响的有用工具。